Olenox Industries has ended a standby equity arrangement that could have allowed it to sell an investor up to $100 million of newly issued stock. The company received no money and sold no shares under that arrangement. In exchange for ending it, Olenox agreed to issue the investor shares now, with a possible additional issuance next year if the stock price falls below a specified level.
Key details
- The agreement, originally signed in May 2025, allowed Olenox to sell shares to the investor over time, subject to the agreement’s conditions. It also included a registration-rights agreement.
- Olenox and the investor terminated both agreements on October 27, 2026. The investor did not provide the $100 million commitment, and Olenox sold no shares through the facility.
- In return for the termination, Olenox agreed to issue 298,604 shares to the investor within 14 business days after the termination agreement takes effect.
- Olenox must issue additional shares on April 27, 2027, if the 10-day volume-weighted average share price before that date is below $0.80. The additional shares are intended to bring the value of the termination shares to at least $258,440.
- The shares will carry a restrictive legend, limiting their resale under applicable securities rules.
Plain-English implications
The $100 million equity facility is no longer available to Olenox, and it produced no proceeds before being terminated. The company’s immediate obligation is to issue 298,604 shares; the number could increase in 2027 if the specified price condition is met. The termination therefore replaces a potential source of future equity funding with a defined share issuance and a conditional additional issuance.